Quest Diagnostics Inc financial data

Symbol
DGX on NYSE
Location
500 Plaza Drive, Secaucus, NJ
Fiscal year end
December 31
Former names
CORNING CLINICAL LABORATORIES INC (to 3/19/1997)
Latest financial report
10-Q - Q1 2025 - Apr 23, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 118 % +10.2%
Quick Ratio 9.63 % -0.82%
Return On Equity 13.2 % -0.6%
Return On Assets 5.79 % -6%
Operating Margin 13.7 % +1.26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 112M shares +0.49%
Entity Public Float 15.2B USD -3.19%
Common Stock, Value, Issued 2M USD 0%
Weighted Average Number of Shares Outstanding, Basic 111M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 113M shares +0.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 10.2B USD +9.38%
Cost of Revenue 6.82B USD +9.43%
Costs and Expenses 8.77B USD +9.17%
Operating Income (Loss) 1.39B USD +10.7%
Nonoperating Income (Expense) -207M USD -50%
Income Tax Expense (Benefit) 266M USD +6.83%
Net Income (Loss) Attributable to Parent 897M USD +6.03%
Earnings Per Share, Basic 8.01 USD/shares +6.38%
Earnings Per Share, Diluted 7.91 USD/shares +6.46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 188M USD -60.3%
Accounts Receivable, after Allowance for Credit Loss, Current 1.4B USD +6.2%
Inventory, Net 189M USD +4.42%
Assets, Current 2.08B USD -6.87%
Property, Plant and Equipment, Net 2.1B USD +15.9%
Operating Lease, Right-of-Use Asset 656M USD +13.3%
Intangible Assets, Net (Excluding Goodwill) 1.73B USD +44.7%
Goodwill 8.85B USD +13%
Other Assets, Noncurrent 260M USD +42.9%
Assets 15.8B USD +13.2%
Employee-related Liabilities, Current 479M USD +25.7%
Accrued Liabilities, Current 306M USD +6.62%
Liabilities, Current 1.44B USD -37.3%
Long-term Debt and Lease Obligation 5.86B USD +54%
Operating Lease, Liability, Noncurrent 538M USD +10%
Other Liabilities, Noncurrent 917M USD +12.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -83M USD -419%
Retained Earnings (Accumulated Deficit) 9.49B USD +6.21%
Stockholders' Equity Attributable to Parent 6.93B USD +7.73%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.96B USD +7.62%
Liabilities and Equity 15.8B USD +13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 314M USD +104%
Net Cash Provided by (Used in) Financing Activities -561M USD -267%
Net Cash Provided by (Used in) Investing Activities -115M USD +46%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 162M shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -361M USD -70.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 188M USD -60.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 250M USD +71.2%
Deferred Tax Assets, Valuation Allowance 35M USD +12.9%
Operating Lease, Liability 708M USD +7.93%
Depreciation 380M USD +12.8%
Payments to Acquire Property, Plant, and Equipment 117M USD +12.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 830M USD -2.12%
Lessee, Operating Lease, Liability, to be Paid 794M USD +8.03%
Property, Plant and Equipment, Gross 5.77B USD +10.3%
Operating Lease, Liability, Current 173M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 170M USD +17.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 194M USD +12.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 7M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 86M USD +8.86%
Lessee, Operating Lease, Liability, to be Paid, Year Three 139M USD +20.9%
Deferred Tax Assets, Operating Loss Carryforwards 95M USD +20.3%
Unrecognized Tax Benefits 124M USD +37.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 105M USD +14.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 137M USD +23.4%
Depreciation, Depletion and Amortization 517M USD +15.4%
Interest Expense 183M USD +22.8%
Preferred Stock, Par or Stated Value Per Share 1 USD/shares 0%